Moving liquids with sound: The launch of a path-breaking technology-Mark Fischer-Colbrie-06/21/2011 - 8:30am

Event Information
Event Topic: 
Moving liquids with sound: The launch of a path-breaking technology
Event Date: 
06/21/2011 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Avenue, Sunnyvale, CA
Speaker Information
Event Speaker: 
Mark Fischer-Colbrie
Event Speaker Title: 
President & CEO
Event Speaker Company: 
Labcyte, Inc.
Event Speaker Bio: 

Mr. Fischer-Colbrie was named President and CEO of Labcyte Inc. in September 2008. He has over 30 years of experience in the areas of diagnostics, medical devices, therapeutics and high technology and has been involved in three Initial Public Offerings. Prior to joining Labcyte, Mr. Fischer-Colbrie was Chief Financial Officer at Adeza Biomedical Corporation, a women’s health care company, which became public in December 2004 and was subsequently sold for over $450 million. During his six year tenure, Mr. Fischer-Colbrie was inventor and co-inventor on six patent applications and ran the Business Development function. Prior that role, Mr. Fischer-Colbrie was the Chief Financial Officer for nearly nine years at an ophthalmology company. At a manufacturer of disk drives that grew from a start-up to $1.2 billion in revenue in eight years, he held several positions including Vice-President, Finance, Corporate Controller and Advanced Technology Business Manager.
Mr. Fischer-Colbrie holds a BA from Stanford University and an MBA in Marketing and Finance from the University of California at Berkeley. He has served in numerous roles for the Juvenile Diabetes Research Foundation and is currently on the Executive Board for the Greater Bay Area. He is also a member of committees of the JDRF International Board as well as part of the JDRF National Speaker's Program.

Event Details
Event Details: 

Labcyte Inc. has developed and commercialized a revolutionary approach to transferring liquids by using exclusively sound energy. Using acoustics, Labcyte is able to transfer volumes over a wide range, including less than a billionth of a liter. This capability has revolutionized pharmaceutical applications and has been adopted by the top pharmaceutical companies. It generates significantly better results while avoiding the problems and costs associated with traditional instrumentation. Initially used in life sciences, including for needs in genomics, proteomics, compound management, high through-put screening, cell transfer and diagnostics, the Labcyte technology can be employed across a variety of industries. The acoustic energy transfer process can make arrays, coat other materials, encapsulate one material within another, move liquids with a high-level of viscosity and other applications for a broad range of uses.